Pivotal bioequivalence trial of modified vs original REMOXY [oxycodone extended-release capsules].
Phase of Trial: Phase I
Latest Information Update: 11 May 2015
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Pharmacokinetics; Registrational
- Sponsors Pfizer
- 11 May 2015 Status changed from not yet recruiting to completed, as reported in a Pain Therapeutics media release.
- 24 Oct 2013 New trial record